Compare AU

Compare IGRO vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

iShares High Growth Esg ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares High Growth Esg ETF (IGRO) and the Global X S&P Biotech ETF (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

IGRO

CURE

Popularity

Low

Low

Pearlers invested

7

83

Median incremental investment

$670.06

$619.50

Median investment frequency

Monthly

Monthly

Median total investment

$2,861.04

$1,437.24

Average age group

> 35

> 35


Key Summary

IGRO

CURE

Strategy

IGRO.AX was created on 2022-08-15 by iShares. The fund's investment portfolio concentrates primarily on target outcome asset allocation. The Fund aims to provide investors with the performance of the various indices of the Underlying Funds

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

iShares Core MSCI Wld Ex Aus ESG ETF (40.70 %)

iShares Core MSCI Australia ESG ETF (35.56 %)

iShares Core MSCI Wld ex Aus ESG AUHDETF (14.75 %)

Natera Inc (3.33 %)

Incyte Corp (2.95 %)

Gilead Sciences Inc (2.81 %)

Top 3 industries

Other (99.98 %)

Communication Services (0.02 %)

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (47.22 %)

Australia (36.23 %)

Japan (3.92 %)

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.22 %

0.45 %


Key Summary

IGRO

CURE

Issuer

iShares

Global X

Tracking index

34% MSCI Australia IMI Custom ESG Leaders Index - 43% MSCI World Ex Australia Custom ESG Leaders Index - 13% MSCI World Ex Australia Custom ESG Leaders Index AUD Hedged - 10% Other Benchmark - Benchmark TR Net

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.22 %

0.45 %

Price

$34.06

$51.33

Size

$10.554 million

$36.301 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.32 %

4.24 %

Market

ASX

ASX

First listed date

16/08/2022

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

IGRO

CURE

Popularity

Low

Low

Pearlers invested

7

83

Median incremental investment

$670.06

$619.50

Median investment frequency

Monthly

Monthly

Median total investment

$2,861.04

$1,437.24

Average age group

> 35

> 35


Pros and Cons

IGRO

CURE

Pros

  • Higher exposure to AU market

  • Lower management fee

  • Higher price growth

  • Higher exposure to US market

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Lower distribution yield

  • Lower exposure to AU market

  • Higher management fee

  • Lower price growth

IGRO

CURE

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home